Wierenga Wendall

Cytokinetics, Incorporated - Common Stock · Director

Wierenga Wendall is listed in public filings as director. This Wierenga Wendall insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Cytokinetics, Incorporated - Common Stock (CYTK), and Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) (CRNX). Investors use Wierenga Wendall's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Cytokinetics, Incorporated - Common StockCYTK$769k20k sharesSellApr 21, 2025$38.46--